Lantern Pharma Inc. (LTRN) has 21 open-market insider trades by 11 insiders since 2020. Over the last six months insiders net bought $200K. The most active filer is BP Directors, LP, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Cavu Management, LP | 10% Owner | — | 2 | $3.0M | 2023-11-29 |
| BIOS Fund I, LP | 10% Owner | — | 3 | $1.4M | 2025-06-12 |
| Aaron G.l. Fletcher | 10% Owner | — | 2 | $1.3M | 2024-05-24 |
| BP Directors, LP | 10% Owner | — | 4 | $1.2M | 2025-06-13 |
| Bios Equity Partners II, LP via BP Directors, LP | 10% Owner | — | 1 | $1.1M | 2024-02-29 |
| Cavu Advisors, LLC | 10% Owner | — | 3 | $702K | 2025-06-12 |
| D. Jeffrey Keyser | Dir | — | 2 | $250K | 2026-05-12 |
| BIOS Advisors GP, LLC | 10% | — | 1 | $168K | 2025-05-29 |
| BIOS Fund II QP, LP | 10% | — | 1 | $124K | 2025-06-13 |
| Lee Troy Schalop | Dir | — | 1 | $100K | 2026-05-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Lee Troy Schalop | Director | Buy | $100K | 2026-05-12 |
| BIOS Fund II QP, LP | 10% | Sell | $124K | 2025-06-13 |
| BIOS Fund I, LP | 10% | Sell | $208K | 2025-06-10 |
| Cavu Advisors, LLC | 10% Owner | Sell | $344K | 2025-06-10 |
| BIOS Advisors GP, LLC | 10% | Sell | $168K | 2025-05-27 |
| Cavu Advisors, LLC | 10% | Sell | $189K | 2024-05-23 |
Companies that share insiders with LTRN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Aaron G.l. Fletcher | 10% Owner | Sell | $277K | 2024-05-23 |
| Bios Equity Partners II, LP | 10% Owner | Sell | $1.1M | 2024-02-27 |
| BP Directors, LP | 10% | Sell | $600K | 2024-02-27 |
| BP Directors, LP | 10% Owner | Sell | $472K | 2024-01-17 |
| BIOS Fund I, LP | 10% | Sell | $247K | 2024-01-17 |
| Aaron G.l. Fletcher | 10% Owner | Sell | $1000K | 2023-11-29 |
| Cavu Management, LP | 10% | Sell | $500K | 2023-11-29 |
| BIOS Fund I, LP | 10% | Sell | $957K | 2022-11-08 |
| Cavu Management, LP | 10% Owner | Sell | $2.5M | 2022-11-08 |